KAREN RABIN

Concepts (395)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with KAREN RABIN's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that KAREN RABIN has written about over time.
Antineoplastic Agents, 9 publications between 2008 and 2026, average publication date May 2017. Leukemia, 6 publications between 2009 and 2023, average publication date July 2018. Down Syndrome, 27 publications between 2008 and 2025, average publication date April 2019. Prognosis, 28 publications between 2008 and 2026, average publication date June 2019. Ikaros Transcription Factor, 4 publications between 2015 and 2021, average publication date July 2019. Disease-Free Survival, 16 publications between 2008 and 2024, average publication date September 2019. Humans, 122 publications between 2004 and 2026, average publication date January 2020. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 72 publications between 2008 and 2026, average publication date January 2020. Child, Preschool, 49 publications between 2008 and 2026, average publication date February 2020. Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, 19 publications between 2009 and 2026, average publication date April 2020. Child, 98 publications between 2008 and 2026, average publication date July 2020. Philadelphia Chromosome, 3 publications between 2017 and 2024, average publication date October 2020. Antineoplastic Combined Chemotherapy Protocols, 16 publications between 2011 and 2026, average publication date February 2021. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 12 publications between 2016 and 2025, average publication date May 2021. Neoplasm Recurrence, Local, 6 publications between 2015 and 2025, average publication date June 2021. Leukemia, Myeloid, Acute, 12 publications between 2013 and 2026, average publication date March 2022. Methotrexate, 11 publications between 2018 and 2025, average publication date September 2022. Antimetabolites, Antineoplastic, 8 publications between 2018 and 2026, average publication date April 2023. Leukemoid Reaction, 1 publications between 2023 and 2023, average publication date August 2023.

To see the data from this visualization as text, click here.
RABIN's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (395)
Explore
_
Co-Authors (58)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_